Adma Biologics | ADMA - Interest Expense On Debt

Stock Price
17.44
Daily Change
-0.06 -0.34%
Monthly
-3.27%
Yearly
3.20%
Q1 Forecast
16.77

Adma Biologics reported $1.68M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Adma Biologics USD 1.68M 150K Sep/2025
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Dynavax Technologies USD 1.64M 2K Sep/2025
Takeda JPY 123.63B 40.49B Dec/2025